Skip to content

Clinical trials

Phase 2 Thrombocytopenia trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Phase: Phase 2 Country / region: France Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20091
20111
20141
20151
20192
20211
20221
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre Hospitalier Universitaire de Saint Etienne2
GlaxoSmithKline2
Associazione Qol-one1
Centre Henri Becquerel1
Centre Leon Berard1
Karyopharm Therapeutics Inc1
Nantes University Hospital1
Takeda1
University Hospital, Lille1
University Hospital, Toulouse1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia12
Glioblastoma2
Hemorrhage2
Primary Myelofibrosis2
Anemia1
Hematologic Neoplasms1
Hepatitis C1
Hepatitis C, Chronic1
Infections1
Lymphoma1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.